Место медицинского обслуживания и лечения в системе права социального обеспечения
The significance of medical care and treatment in social security law is analysed.
Main reports of X scientific and practical conference "Functions of the labor law and social security law", within the VI international scientific and practical conference Kutafinsky readings 4-5 April , 2014."Kutafinsky chtenia"
Textbook reflects the current level of development of social security law , the judicial practice of its implementation, the issues in dispute to be solved. Particular attention is paid to issues related to financing the social security system, ensuring its stability and warranty. The manual includes a section on regulatory frameworks social security abroad. Structure and volume of the material presented in the textbook , the curriculum meets the National Research University "Higher School of Economics" and takes into account the latest provisions of the legislation in this area. Its main objective - to help students in mastering the basic theoretical knowledge of the issues of social security law and the ability to navigate the complex legislation in the industry. At the end of chapters are questions for self . The manual is prepared in accordance with the requirements of the Federal state educational standard of higher education and the third generation includes the entire list of topics needed to build the required competencies and skills. Designed for bachelors, masters and PhD students of higher educational institutions , practitioners and all those interested in issues of social security law.
Control of heart rate (HR) is an important target during treatment of patients with stable angina. In a number of cases it can be achieved by the use of β adrenoblockers. But often a necessity arises to enhance pulse slowing therapy with the use of combinations of drugs exerting negative chronotropic effect. We present here results of the CONTROL study (n=1777), conducted with the aim of studying antianginal efficacy and tolerability of the If channels blocker ivabradine used in combination with β adrenoblockers in patients with stable functional class II-III angina and frequency of attacks ≥3/week and HR>70 bpm. The use of ivabradine for 12 weeks allowed to achieve greater reduction of frequency of anginal attacks (by 4 per week, 95% confidence interval 3-6) compared with the group of usual care (treatment at physicians discretion). At the end of the study in ivabradine group 43% of patients had no angina at all, HR lowering ≤60 bpm was noted in 46% of patients (in the comparison group14 and 6%, respectively, p<0.001). Reduction of frequency of attacks of angina correlated with HR lowering, more with pulse rate measured by patients themselves (r=0.411, p<0.001), than with values measured at visits to physicians (r=0.266, p<0.001). Rate of lethal outcomes as well as rate of nonfatal cardiovascular complications (myocardial infarction, stroke, urgent revascularization) were similar in compared groups. In ivabradine group compared with usual care group there were less hospitalizations (5.0 and 8.6%, respectively, p=0.021), calls for emergency service (13.3 and 25.4%), and sick leaves (6.6 and 13.1%, p=0.018). Adverse reactions were noted in 130 patients (8.7%) in ivabradine group and in 29 patients (10.0%) in usual care group p=0.580).
The emergence on the Russian market of new forms of sales and services, like online-shopping, has formed a new sphere of communication - client/customer service to the actual and potential clients/customers by email. This area is actively developing in Russia for the last 10 years. On the basis of the analysis of the examples of e-mails, sent to the real people by the customer services of 115 different companies, the author formulates the main trends of the use of forms of address in this sphere.
Abstract The paper presents a meta-analysis of open-label antihypertensive effectiveness studies of indapamide SR (Arifon Retard, Servier Laboratories, France) in hypertensives. 24 Russian (n = 4952) and 4 foreign (n = 4634) studies were included in analysis. Russian studies show that indapamide retard both as a monotherapy and a component of the combination therapy leads to a 17,8/14,0 % decrease of systolic/diastolic blood pressure that is a reduction for 29.2 (95 % CI 28,9–29,5)/12,3 (12,1–12,5) mmHg in patients with uncontrolled hypertension. Baseline blood pressure was the main predictor of its reduction, and the most signifi cant reduction for 32,6 (95 % CI 25,5–39,6) mmHg was seen when the average baseline systolic blood pressure exceeded 170 mmHg. Antihypertensive effi cacy of indapamide retard was similar in Russian and foreign studies. However, incidence of therapy-related side effects was higher in Russian studies than in foreign ones (5,9 and 3,3 % respectively, p < 0,001). Therefore, meta-analysis based on the data of open Russian studies confi rms the antihypertensive effectiveness of indapamide retard and demonstrates the comparability of the results to those found in multicenter foreign studies.